Novartis Investigative Site

Garmisch-Partenkirchen 82467

0 studies enrolling now · 2 studies all time

What they study most

Neoplasms, Breast, Systemic Juvenile Idiopathic Arthritis

Studies at this site

• ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D — Completed
• An Open-label Extension Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis and Active Systemic Manifestations Manifestations and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever. — Completed